Dudediligence.

Adicet Bio, Inc

ACETNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,191,969

3 notices · 183,157 sh

Oct 2025 to Oct 2026

Reported ·

$674,847

4 sales · 5 buys · $6,603,934 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 4 reported sales carry the 10b5-1 box. Together they are 1.12% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-04-09: OrbiMed Genesis Master Fund, L.P., Form 1442026-04-08: OrbiMed Israel Partners II, L.P., Form 1442026-04-07: OrbiMed Israel Partners Limited Partnership, Form 1442025-10-08: ORBIMED ADVISORS LLC, bought2026-02-18: RA Capital Healthcare Fund LP, bought2026-04-07: ORBIMED ADVISORS LLC, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-04-09OrbiMed Genesis Master Fund, L.P., Shareholder$514,168
78,499 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-08OrbiMed Israel Partners II, L.P., Shareholder$264,725
40,416 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-07OrbiMed Israel Partners Limited Partnership, Shareholder$413,076
64,242 shno plan date144 ↗
Form 4, 2026-04-09: sold 104,658 at $6.45 Form 4 ↗